Status:
TERMINATED
Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.
Lead Sponsor:
Sheba Medical Center
Conditions:
Crohn's Disease
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study is aimed to assess the hypothesis that instillation of fibrin glue with the induction of local conditions using Infliximab, may be useful in the treatment of perianal Crohn's disease.
Detailed Description
Patients with perianal fistulae of Crohn's disease will be prospectively enrolled and receive 3 doses of Infliximab. If reduction of fistula associated discharge of at least 50% will be recorded, comm...
Eligibility Criteria
Inclusion
- Perianal fistula of Crohn's dis
Exclusion
- More then 2 fistulae perianal sepsis known contraindication to infliximab or glue
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00252369
Last Update
April 24 2009
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel
2
Tel Aviv Medical Center
Tel Aviv, Israel
3
Sheba Medical Center
Tel Litwinsky, Israel
4
Assaf Harofe Medical Center
Zrifin, Israel